Type 1 diabetes
-
Quick comparison of Medtronic, Abbott, Dexcom, Senseonics CGMs from ADA 2019
At the annual meeting of the American Diabetes Association meeting last week, a diabetes epidemiologist compares and contrasts competing CGMs both based on features and accuracy.
-
When it comes to diabetes devices and apps, FDA prefers mixing and matching
On the day that an FDA official exhorts industry to develop interoperable diabetes devices, Medtronic announces that it is teaming up with a nonprofit group to do just that.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
FDA’s Gottlieb proposes biosimilar pathway to tackle skyrocketing insulin prices
Insulin prices have shot up nearly 600 percent, according to a congressional study, leading to potentially deadly rationing by many patients.
-
This is what empowered patients desire on their journey
During a November 6 breakout session at MedCity ENGAGE, panelists shared that patients should be their own advocates, be part of their care team and stay informed.
-
Digital health startup Klue adds diabetes feature with insulin reminders
The company, whose technology pairs with the Apple Watch and detects hand gestures, has a new feature that includes a reminder for mealtime insulin administration.
-
Bigfoot brings in $55M Series B to propel integrated diabetes platform
The California startup is attempting to create a closed-loop and integrated diabetes platform that attracted Abbott, whic has been a partner since July to invest.
-
FDA clears new Dexcom CGM that requires no patient calibration earlier than expected
Months ahead of schedule, FDA clears the use of DexCom’s latest continuous glucose monitoring system for patients two and up, freeing them from routine fingerstick calibration.
-
Medtronic’s MiniMed 670G insulin delivery system gave me peace of mind
After a Type 1 patient penned a post on why she didn’t think Medtronic’s 670G hailed as the first artificial pancreas was all that, another patient who uses the device writes it’s exactly that and then some.
-
Why I won’t be switching to Medtronic’s 670G insulin delivery system billed as the first artificial pancreas
As a type 1 diabetes patient, I have decided to stay on an open-source insulin delivery solution instead of switching to a hybrid closed-loop insulin delivery system from Medtronic whose FDA approval was widely hailed.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Dexcom shares take a hit as Abbott’s CGM system gets CMS nod
A sooner-than-expected availability of a rival’s continuous glucose monitoring system to Medicare patients sends Dexcom’s stocks lower, but an analyst believes this will be temporary.
-
IBM and JDRF bring machine learning to type 1 diabetes research
IBM and the Juvenile Diabetes Research Fund are teaming up to pinpoint the factors that lead to the onset of type 1 diabetes in children.
-
“Make beta cells great again:” Type 1 diabetes interventions at ADA 2017
The development of type 1 diabetes starts years before symptoms appear, which raises the possibility of early intervention, prevention, or possibly even reversal of the disease. Such efforts were discussed on Monday at the American Diabetes Association’s Scientific Sessions.
-
Revised AHCA sparks controversy
The AHCA is back on the table, but not everyone is on board. Organizations like JDRF and even some House Republicans dissent, saying it increases burdens on those with pre-existing conditions.
-
CMS’s landmark ruling on continuous glucose monitors is like sweet music to DexCom
Medicare announced that therapeutic continuous glucose monitors that help to make treatment decisions will be considered durable medical equipment and covered, a move hailed by many.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
